Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Simponi receives positive opinion in Europe for treatment of pJIA

May 31, 2016

Mutations in ZAS may be associated with congenital myopathy

May 24, 2016

Bone Therapeutics reports results from phase I/II trial of ALLOB

May 18, 2016

Ampio Pharmaceuticals begins Ampion phase I trial dosing

May 13, 2016

PABPN1 gene knockdown plus restoration partially restores muscle function in OPMD mice

May 13, 2016

Pfenex announces topline bioequivalence data for PF-708

May 10, 2016

Vitaeris obtains rights to Alder BioPharmaceuticals' clazakizumab

May 10, 2016

Cumberland Pharmaceuticals commences new systemic sclerosis program for ifetroban

April 28, 2016

FDA grants orphan drug designation to Fibrocell Science's FCX-013

April 27, 2016

Protalex reports early results from phase I/II PRTX-100 study in RA

April 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...